If there’s one piece of pharma news that should come as no surprise, it’s FDA throwing a new drug back at its maker with a “Try again later.” After all, the agency spent last year handing out “approvable” letters like pharma hands out freebies. That’s why we’re surprised that analysts, reporters, and possibly […]

[Read more →]

If, in the wake of the sale of Millennium, you’ve been wondering what ever happened to the company’s co-founder and longtime CEO Mark Levin, the answer was in this morning’s deal news, in the announcement that a young biotech called Constellation Pharmaceuticals had closed a $32 million Series A financing. The companies coming up with […]

[Read more →]

Less than 24 hours after skewering CEO Jeffrey Kindler (right) in the press following Pfizer’s dismal Analyst Day, Wall Street’s large-cap analysts have done a stunning turnaround. In a rare show of remorse at their pitiless pile-on, these freshly contrite gurus of the pharma sector have declared the next five business days “Be Kinder to […]

[Read more →]

This just in: The Healthcare Businesswomen’s Association (HBA) just announced its Woman of the Year. (Better known as WOTY, for those in the inner circle.)
At this year’s luncheon, held on May 8 at the New York Hilton, HBA will hand the WOTY honor to Charlotte Sibley, senior vice president, leadership development for Shire. This […]

[Read more →]

After eight years at CCA Advertising, Mike Devlin has left to join Concentric Advertising, as head of its new pharma consumer shop.
This follows some of the general shuffling that’s taken place at CCA Advertising since inVentiv’s $65 million buyout of the company. Some report that CCA is pushing much of its consumer work under its […]

[Read more →]

The board of directors of Shire announced its board-succession plans on Dec. 13. Dr. James H. Cavanaugh will retire as non-executive chairman; Matthew Emmens will succeed him as non-executive chairman. Angus Russell will be appointed chief executive. David Kappler will be appointed as deputy chairman in addition to his existing role as senior independent director.

[…]

[Read more →]